Paul Howard discusses research showing that limits on pharmaceutical companies communications with doctors can have unintended consequences for physicians' practice patterns and patients

Paul Howard discusses George Chressanthis and Patrap Khedkar's research showing that limits on pharmaceutical companies communications with doctors can have unintended consequences for physicians' practice patterns and patients.